
1,3-Divinyl-1,3-diphenyl-1,3-dimethyldisiloxane | CAS:2627-97-6
1,3-Divinyl-1,3-diphenyl-1,3-dimethyldisiloxane
- 名称:1,3-二乙烯基-1,3-二苯基-1,3-二甲基二硅氧烷 | 1,3-Divinyl-1,3-diphenyl-1,3-dimethyldisiloxane
- CAS号:2627-97-6
- 别名:
- 分子式:C18H22OSi2
- 分子量:310.54
- EINESC号:220-101-5
产品描述
物理化学性质
沸点 | 318.9±15.0 ºC (760 Tor |
---|---|
闪点 | 122.9±20.8 ºC, 计算值* |
密度 | 0.98±0.1 g/cm3 (20 ºC |
折射率 | 1.531 (589.3 nm 25 ºC)** |
安全数据
没有数据 | 没有数据 |
---|
SDS
来源 | SDS样本 |
---|---|
没有数据 | 没有数据 |
产品合成路线
名称 | CAS号 |
---|
更多
文章
同行评议文献
Joint Diseases: New Insights for the Healthcare Professional, 13-13 (2013)
[2010 German Pain Congress. Backache - new data, specific muscle etiology and targeted therapy].Andreas Häckel MMW Fortschritte der Medizin, 152(51-52), 40-41 (2011-02-08)
Flupirtine enhances the anti-hyperalgesic effects of morphine in a rat model of prostate bone metastasis.Anton Kolosov et al.Pain medicine (Malden, Mass.), 13(11), 1444-1456 (2012-10-20)
Flupirtine-induced hepatic failure requiring orthotopic liver transplant.Fritz Klein et al.Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation, 9(4), 270-272 (2011-08-09)
M channel enhancers and physiological M channel block.John E Linley et al.The Journal of physiology, 590(4), 793-807 (2011-12-14)
Transcriptional repression of the M channel subunit Kv7.2 in chronic nerve injury.Kirstin Rose et al.Pain, 152(4), 742-754 (2011-02-25)
Protein Surface Structural Recognition in Inactive Areas: A New Immobilization Strategy for Acetylcholinesterase.Jianxiong Diao et al.Bioconjugate chemistry, 29(5), 1703-1713 (2018-04-05)
Concomitant facilitation of GABAA receptors and KV7 channels by the non-opioid analgesic flupirtine.Felicia Klinger et al.British journal of pharmacology, 166(5), 1631-1642 (2011-12-23)
Flupirtine is a safe alternative drug in patients with hypersensitivity to NSAIDs.Regina Treudler et al.European journal of clinical pharmacology, 67(9), 961-963 (2011-03-10)
Efficacy and tolerability of flupirtine in subacute/ chronic musculoskeletal pain - results of a patient level, pooled re-analysis of randomized, double-blind, controlled trials.M A Ueberall et al.International journal of clinical pharmacology and therapeutics, 49(11), 637-647 (2011-10-21)
Efficacy and safety of flupirtine modified release for the management of moderate to severe chronic low back pain: results of SUPREME, a prospective randomized, double-blind, placebo- and active-controlled parallel-group phase IV study.Michael A Uberall et al.Current medical research and opinion, 28(10), 1617-1634 (2012-09-14)
Efficacy and safety of flupirtine maleate and tramadol hydrochloride in postoperative pain management--a prospective randomised double blinded study.Syed Mohammed Naser et al.Journal of the Indian Medical Association, 110(3), 158-160 (2012-10-04)
Parent-reported benefits of flupirtine in juvenile neuronal ceroid lipofuscinosis (Batten disease; CLN3) are not supported by quantitative data.Jennifer Cialone et al.Journal of inherited metabolic disease, 34(5), 1075-1081 (2011-05-11)
Unexpected frequent hepatotoxicity of a prescription drug, flupirtine, marketed for about 30 years.Martin C Michel et al.British journal of clinical pharmacology, 73(5), 821-825 (2011-11-03)
Protective effect of the KCNQ activator flupirtine on a model of repetitive febrile seizures.Fang Yu et al.Epilepsy research, 97(1-2), 64-72 (2011-08-13)
Flupirtine, a re-discovered drug, revisited.Istvan Szelenyi Inflammation research : official journal of the European Histamine Research Society ... [et al.], 62(3), 251-258 (2013-01-17)
[Chronic backache. Rational therapy of muscle-induced pain]. MMW Fortschritte der Medizin, 154(3), 86-87 (2012-03-31)
Flupirtine inhibits calcitonin-gene related peptide release from rat brainstem in vitro.Giuseppe Tringali et al.Neuroscience letters, 506(2), 332-335 (2011-12-14)
[Flupirtin (katadolon): a nonstandard action on pain transmission].V V Alekseev Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 111(4), 101-104 (2011-09-09)
[Effect of maladaptive sets on the clinical picture and prediction of chronic headache of tension].I G Podymova et al.Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 111(4), 4-7 (2011-04-23)
Retigabine, a K(V)7 (KCNQ) potassium channel opener, attenuates L-DOPA-induced dyskinesias in 6-OHDA-lesioned rats.S E Sander et al.Neuropharmacology, 62(2), 1052-1061 (2011-11-15)
Pathology of flupirtine-induced liver injury: a histological and clinical study of six cases.Florian Puls et al.Virchows Archiv : an international journal of pathology, 458(6), 709-716 (2011-05-19)
[Musculoskeletal pain. Pain relief with muscle relaxant]. MMW Fortschritte der Medizin, 152(48), 37-37 (2011-01-13)
Bioanalytical method development, validation and quantification of flupirtine maleate in rat plasma by liquid chromatography-tandem mass spectrometry.Karthikeyan Kandasamy et al.Arzneimittel-Forschung, 61(12), 693-699 (2012-01-28)
Role of Kv7 channels in responses of the pulmonary circulation to hypoxia.Vojtech Sedivy et al.American journal of physiology. Lung cellular and molecular physiology, 308(1), L48-L57 (2014-11-02)
Dependence on flupirtine.Maximilian Gahr et al.Journal of clinical pharmacology, 53(9), 1003-1004 (2013-07-13)
M-type potassium channels modulate Schaffer collateral-CA1 glutamatergic synaptic transmission.Jianli Sun et al.The Journal of physiology, 590(16), 3953-3964 (2012-06-08)
Kv7 potassium channels in airway smooth muscle cells: signal transduction intermediates and pharmacological targets for bronchodilator therapy.Lioubov I Brueggemann et al.American journal of physiology. Lung cellular and molecular physiology, 302(1), L120-L132 (2011-10-04)
Correlation versus causation? Pharmacovigilance of the analgesic flupirtine exemplifies the need for refined spontaneous ADR reporting.Nora Anderson et al.PloS one, 6(10), e25221-e25221 (2011-10-25)
备注
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
名称 | CAS号 |
---|

相关产品
相关资讯
问
热门标签
询 单
请 填 写 相 关 信 息
- 请填写产品名称!
- CAS号
- 请正确填写公司名称!
- 请正确填写联系人!
- 请正确填写联系电话!
- 请正确填写联系邮箱!
- 请描述您的问题!